Through case presentations, the panel will discuss novel office-based treatment options for common sinonasal complaints (such as nasal obstruction, eustachian tube dysfunction and postnasal drainage) and diagnoses (including rhinitis and rhinosinusitis). Several office-based treatments will be highlighted that received FDA approval or new billing codes within the last 2-3 years. Practicing ENT surgeons can now offer cryotherapy or radiofrequency for postnasal drainage, radiofrequency remodeling for nasal obstruction and chronic rhinitis, steroid-eluting devices for recurrent nasal polyps, balloon dilation for eustachian tube dysfunction, and nasal implants for nasal congestion. These physicians should understand these technologies, their efficacy and their indications. With most new technology, reimbursement and appropriate coding can be uncertain. New codes will be reviewed. In this program, the panel will discuss the new treatments and review the mechanism of action and data on their efficacy through case presentations. In addition, the presentation will delve into reimbursement options and business practice implications with these office-based treatments. Finally, appropriate coding associated with these treatment options will also be discussed.